Cerus (CERS) Cash & Equivalents (2010 - 2026)
Cerus (CERS) reported Cash & Equivalents of $27.8 million for Q1 2026, up 43.0% on a YoY basis from $19.5 million in Q1 2025, and up 39.52% sequentially from $20.0 million in Q4 2025.
Cerus (CERS) Cash & Equivalents (2010 - 2026) Analysis & Trends
Cerus (CERS) has 17 years of Cash & Equivalents data on file, last reported at $27.8 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Equivalents rose 43.0% year-over-year to $27.8 million; the trailing twelve-month figure through Mar 2026 stood at $27.8 million (up 43.0% YoY), and the FY2025 full-year result was $20.0 million, down 1.5% from the prior year.
- Cash & Equivalents improved to $27.8 million in Q1 2026, from $20.0 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $38.4 million in Q1 2022 to a low of $11.6 million in Q4 2023.
- A 5-year average of $22.7 million and a median of $20.5 million in 2024 frame the typical range for Cash & Equivalents.
- Across the five-year window, Cash & Equivalents sank 67.27% in 2023 and surged 74.0% in 2024, its largest moves.
- Tracing CERS's Cash & Equivalents over 5 years: stood at $35.6 million in 2022, then slumped by 67.27% to $11.6 million in 2023, then surged by 74.0% to $20.3 million in 2024, then declined by 1.5% to $20.0 million in 2025, then soared by 39.52% to $27.8 million in 2026.
- Business Quant data shows CERS's Cash & Equivalents at $27.8 million in Q1 2026, $20.0 million in Q4 2025, and $15.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 176.50 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 128.84 Bn | 125.96 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 68.51 Bn | 67.06 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.18 Bn | 44.51 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 28.16 Bn | 25.88 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | 557.00 Mn |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | 3.03 Bn |
| 10 | Cerus | 605.72 Mn | 525.30 Mn | 27.89 Mn | 27.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.85 Mn |
| Dec 31, 2025 | 19.96 Mn |
| Sep 30, 2025 | 15.67 Mn |
| Jun 30, 2025 | 15.99 Mn |
| Mar 31, 2025 | 19.48 Mn |
| Dec 31, 2024 | 20.27 Mn |
| Sep 30, 2024 | 21.58 Mn |
| Jun 30, 2024 | 12.40 Mn |
| Mar 31, 2024 | 20.53 Mn |
| Dec 31, 2023 | 11.65 Mn |
| Sep 30, 2023 | 17.39 Mn |
| Jun 30, 2023 | 20.64 Mn |
| Mar 31, 2023 | 27.60 Mn |
| Dec 31, 2022 | 35.59 Mn |
| Sep 30, 2022 | 28.88 Mn |
| Jun 30, 2022 | 32.31 Mn |
| Mar 31, 2022 | 38.37 Mn |
| Dec 31, 2021 | 48.76 Mn |
| Sep 30, 2021 | 78.46 Mn |
| Jun 30, 2021 | 59.03 Mn |